期刊文献+

肝硬化患者血清纤维化指标及血小板相关指标的变化 被引量:8

Change of serum fibrosis indexes and platelet related indexes of patients with hepatocirrhosis
下载PDF
导出
摘要 目的:研究肝硬化患者血清纤维化指标及血小板相关指标的变化。方法:选取本院收治的59例肝硬化患者为观察组,同期59例健康人员为对照组,将两组的血清纤维化指标及血小板相关指标进行比较,并比较不同病因及肝功能分级肝硬化患者的血清纤维化指标及血小板相关指标。结果:观察组的血小板计数(PLT)低于对照组,而血清纤维化指标及其他血小板相关指标均高于对照组,且不同肝功能分级者之间也存在明显的差异,差异具有统计学意义(P<0.05);而不同病因者之间比较,差异无统计学意义(P>0.05)。结论:肝硬化患者血清纤维化指标及血小板相关指标的变化较大,并且受肝功能分级的影响较大,但不同病因者之间无明显差异。 Objective: To observe and study the change state of serum fibrosis indexes and platelet related indexes of patients with hepatocirrhosis. Methods:59 patients with hepatocirrhosis admitted to our hospital from November 2010 to October 2013 were selected as observation group, 59 healthy personnel during the same period were enrolled as control group,then the serum fibrosis indexes and platelet related indexes of two groups were compared, and the serum fibrosis indexes and platelet related indexes of pa- tients with different pathogeny and liver function stages were compared too. Results:The PLT of observation group was lower than that of control group,while the serum fibrosis indexes and other platelet related indexes were all higher than those of control group, and the detection levels of patients with different liver function stages had obvious differences (P all〈0.05), detected parameters of patients with different stages of liver function were also significant different from each other (P〈0.05). Conclusion:The change of serum fibrosis indexes and platelet related indexes of patients with hepatocirrhosis are great, and are affected by severity of liver function, but no significant correlations between the change and pathogeny are found.
作者 陶四玉 张静
出处 《海南医学院学报》 CAS 2014年第6期802-804,808,共4页 Journal of Hainan Medical University
基金 湖北省洪湖市卫生发展基金(sh201223)~~
关键词 肝硬化 纤维化指标 血小板相关指标 Hepatocirrhosis ; Fibrosis indexes ; Platelet related indexes
  • 相关文献

参考文献14

二级参考文献122

共引文献89

同被引文献86

  • 1周怡,方秀敏.认知-心理-社会支持护理干预对改善肝硬化伴上消化道出血患者疾病不确定感的效果分析[J].中国保健营养旬刊,2013,2(2):608-609.
  • 2Mishel MH.Uncertainty in illness scales manual.Dana Epstein MS.College of Nursing,University of Arizona,2014,11(23):98.
  • 3甄真,赵三江,周俊英,刘金星,李兵顺.慢性乙肝患者生长激素-胰岛素样生长因子轴的变化及其临床意义[J].河北医科大学学报,2008,29(1):17-20. 被引量:4
  • 4Martin DJ,Weideman R,Crook T,et al.Relationship of hepatic fibrosis,cirrhosis,and mortality with cholecystectomy in patients with hepatitis C virus infection[J].Eur J Gastroenterol Hepatol,2016,28(2):181-186.
  • 5Yilmaz B,Dayanan R.Letter:reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome[J].Aliment Pharmacol Ther,2015,41(8):794.
  • 6Alboraie M,Khairy M,Elsharkawy M,et al.Value of EgyScore in diagnosis of significant,advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index,FIB-4and Forns'index in chronic hepatitis C virus[J].Hepatol Res,2015,45(5):560-570.
  • 7Ozaki K,Matsui O,Gabata T,et al.Confluent hepatic fibrosis in liver cirrhosis:possible relation with middle hepatic venous drainage[J].Jpn J Radiol,2013,31(8):530-537.
  • 8Rustogi R,Horowitz J,Harmath C,et al.Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis[J].J Magn Reson Imaging,2012,35(6):1356-1364.
  • 9Shiffman ML,James AM,Long AG,et al.Treatment of chronic HCV with sofosbuvir and simeprevir in patients with cirrhosis and contraindications to interferon and/or ribavirin[J].Am J Gastroenterol,2015,110(8):1179-1185.
  • 10Bruno S,Sewpaul P,Russo ML,et al.12weeks of interferonbased therapy is feasible in patients with hepatitis C-related cirrhosis and thrombocytopenia:A post hoc analysis of eltrombopag studies[J].Dig Liver Dis,2015,47(10):864-868.

引证文献8

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部